“Alcoholism is a major problem in the U.S.,” said V. V. N. Phani Babu Tiruveedhula, of the Univ. of Wisconsin, Milwaukee. “Alcohol abuse costs almost $220 billion to the U.S. economy every year. That’s a shocking number. We need…better treatment right now.”
Tiruveedhula is in the midst of developing a new compound to treat alcoholism, and a drug could be available to the market within five to six years. He presented his research at the 250th National Meeting & Exposition of the American Chemical Society (ACS).
“It is very exciting. We found a new way to treat alcoholism, rather than the traditional ways,” he said.
While the underlying causes of alcoholism vary, and can be quite specific to a single person, researchers know alcohol affects the brain’s reward center by releasing dopamine. The neurotransmitter increases in response to pleasurable behavior.
According to Tiruveedhula, current drugs meant to combat alcoholism focus on dopamine, and attempt to dampen the rewards from alcohol-based stimuli. But these opioid antagonists could have adverse side effects. One unintended result is anhedonia, or the inability to feel pleasure, said Tiruveedhula.




